Immunotherapy: on the edge between experimental and clinical oncology.
about
Kinetic model for designing a cancer therapy.Cytotoxic chemotherapy preceding apheresis of peripheral blood progenitor cells can affect the early reconstitution phase of naive T cells after autologous transplantation.T-cell dynamics after high-dose chemotherapy in adults: elucidation of the elusive CD8+ subset reveals multiple homeostatic T-cell compartments with distinct implications for immune competence.
P2860
Immunotherapy: on the edge between experimental and clinical oncology.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Immunotherapy: on the edge between experimental and clinical oncology.
@ast
Immunotherapy: on the edge between experimental and clinical oncology.
@en
Immunotherapy: on the edge between experimental and clinical oncology.
@nl
type
label
Immunotherapy: on the edge between experimental and clinical oncology.
@ast
Immunotherapy: on the edge between experimental and clinical oncology.
@en
Immunotherapy: on the edge between experimental and clinical oncology.
@nl
prefLabel
Immunotherapy: on the edge between experimental and clinical oncology.
@ast
Immunotherapy: on the edge between experimental and clinical oncology.
@en
Immunotherapy: on the edge between experimental and clinical oncology.
@nl
P2860
P356
P1476
Immunotherapy: on the edge between experimental and clinical oncology.
@en
P2093
Fagnoni FF
Robustelli della Cuna G
P2860
P356
10.1179/JOC.2001.13.1.15
P577
2001-02-01T00:00:00Z